Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: a retrospective case- controlled analysis

By Ravhon A.   Lavery S.   Aurell R.   Trew G.   Margara R.   Winston R.  

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 920-925

Elsevier

Access to resources Recommend Favorite

Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study - control and physiological function

By Yarali H.   Bukulmez O.   Gurgan T.  

Fertility and Sterility, Vol. 72, Iss. 2, 1999-08 ,pp. : 276-281

Elsevier

Access to resources Recommend Favorite

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1086-1093

Elsevier

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies

By Kelly E.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1105-1107

Elsevier

Access to resources Recommend Favorite

First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization

By Beckers N.G.M.   Macklon N.S.   Devroey P.   Platteau P.   Boerrigter P.J.   Fauser B.C.J.M.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 621-623

Elsevier

Access to resources Recommend Favorite